CCL2 and Hodgkins lymphoma: Also, we found an evidence for the diagnostic utility of the following markers: MCP-1, eotaxin, IL-10 and IL-6 for NHL and HL and IL-1β for HL, while TNF-α has limited utility due to the poor ability to discriminate amongst patients with lymphoma and healthy control, as well as IL-1β for NHL.